Differential Diagnosis and Clinical Treatment Strategies of Thyroid Nodules.

Thyroid Cancer Clinical Trial

Official title:

Differential Diagnosis and Clinical Treatment Strategies of Thyroid Nodules.

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT02953288
• Other study ID #: Research center of the thyroid
• Status: Active, not recruiting
• Phase: N/A
• First received: November 1, 2016
• Last updated: November 1, 2016
• Start date: October 2016
• Est. completion date: December 2018

Study information

• Verified date: November 2016
• Source: Shanghai 10th People's Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: China: Ethics Committee
• Study type: Observational

Clinical Trial Summary

To investigate the genetic mutations of patients with thyroid carcinoma and find molecular targets for therapy.

Description:

In previous studies, we have found highly prevalent TERT promoter mutations in aggressive thyroid cancers. So we plan to perform further research to investigate the genetic mutations of patients with thyroid carcinoma and find molecular targets for therapy.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 3000
• Est. completion date: December 2018
• Est. primary completion date: June 2017
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Patient with thyroid nodule

Exclusion Criteria:

• Coagulant function abnormality

• pregnant

Study Design

Observational Model: Case-Crossover, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Thyroid Cancer
• Thyroid Diseases
• Thyroid Neoplasms
• Thyroid Nodule

Locations

Country	Name	City	State
China	Department of Endocrinology, Shanghai Tenth People's Hospital	Shanghai	Shanghai

Sponsors (1)

Lead Sponsor	Collaborator
Shanghai 10th People's Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Gene sequencing		2 weeks	Yes